1. Home
  2. ANET vs MRK Comparison

ANET vs MRK Comparison

Compare ANET & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arista Networks Inc.

ANET

Arista Networks Inc.

HOLD

Current Price

$166.67

Market Cap

173.1B

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$117.10

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANET
MRK
Founded
2004
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.1B
268.7B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
ANET
MRK
Price
$166.67
$117.10
Analyst Decision
Strong Buy
Buy
Analyst Count
17
17
Target Price
$175.18
$125.59
AVG Volume (30 Days)
6.3M
7.0M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
2.85%
EPS Growth
23.32
8.01
EPS
2.75
7.28
Revenue
$9,005,700,000.00
$65,011,000,000.00
Revenue This Year
$29.10
$3.61
Revenue Next Year
$21.80
$5.41
P/E Ratio
$59.81
$16.36
Revenue Growth
28.60
1.31
52 Week Low
$67.16
$75.40
52 Week High
$165.28
$125.14

Technical Indicators

Market Signals
Indicator
ANET
MRK
Relative Strength Index (RSI) 74.29 45.73
Support Level $138.18 $116.50
Resistance Level N/A $124.57
Average True Range (ATR) 5.08 2.78
MACD 3.70 -0.47
Stochastic Oscillator 98.86 24.76

Price Performance

Historical Comparison
ANET
MRK

About ANET Arista Networks Inc.

Arista Networks is a networking equipment provider that mainly sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three-quarters of its sales from North America.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: